Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of primary leiomyoma of the liver in a patient without evidence of immunosuppression.
Kanazawa N, Izumi N, Tsuchiya K, Sakurai K, Hamano K, Itakura J, Asahina Y, Noguchi O, Uchihara M, Miyake S, Miyakawa N, Kawachi Y, Shiotsu H, Taki K, Himeno Y, Enomoto N, Watanabe M, Sakai T. Kanazawa N, et al. Among authors: asahina y. Hepatol Res. 2002 Sep;24(1):80. doi: 10.1016/s1386-6346(02)00014-1. Hepatol Res. 2002. PMID: 12243795
Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography.
Asahina Y, Izumi N, Uchihara M, Noguchi O, Ueda K, Inoue K, Nishimura Y, Tsuchiya K, Hamano K, Itakura J, Himeno Y, Koike M, Miyake S. Asahina Y, et al. Hepatol Res. 2003 Nov;27(3):196-204. doi: 10.1016/s1386-6346(03)00261-4. Hepatol Res. 2003. PMID: 14585396
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy.
Hamano K, Sakamoto N, Enomoto N, Izumi N, Asahina Y, Kurosaki M, Ueda E, Tanabe Y, Maekawa S, Itakura J, Watanabe H, Kakinuma S, Watanabe M. Hamano K, et al. Among authors: asahina y. J Gastroenterol Hepatol. 2005 Sep;20(9):1401-9. doi: 10.1111/j.1440-1746.2005.04024.x. J Gastroenterol Hepatol. 2005. PMID: 16105128
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.
Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Honda M, Sugiyama M, Matsuura K, Sugauchi F, Asahina Y, Nakagawa M, Watanabe M, Sakamoto M, Maekawa S, Sakai A, Kaneko S, Ito K, Masaki N, Tokunaga K, Izumi N, Mizokami M. Kurosaki M, et al. Among authors: asahina y. J Hepatol. 2011 Mar;54(3):439-48. doi: 10.1016/j.jhep.2010.07.037. Epub 2010 Sep 19. J Hepatol. 2011. PMID: 21129805
Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.
Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Matsuura K, Asahina Y, Nakagawa M, Watanabe M, Sakamoto M, Maekawa S, Tokunaga K, Mizokami M, Izumi N. Kurosaki M, et al. Among authors: asahina y. J Med Virol. 2013 Mar;85(3):449-58. doi: 10.1002/jmv.23497. Epub 2013 Jan 7. J Med Virol. 2013. PMID: 23297176
Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice.
Kiyohashi K, Kakinuma S, Kamiya A, Sakamoto N, Nitta S, Yamanaka H, Yoshino K, Fujiki J, Murakawa M, Kusano-Kitazume A, Shimizu H, Okamoto R, Azuma S, Nakagawa M, Asahina Y, Tanimizu N, Kikuchi A, Nakauchi H, Watanabe M. Kiyohashi K, et al. Among authors: asahina y. Hepatology. 2013 Jun;57(6):2502-13. doi: 10.1002/hep.26293. Epub 2013 May 14. Hepatology. 2013. PMID: 23386589
286 results